Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Journal

Atherosclerosis

ISSN:
0021-9150
2
h-index
12
Citations
126
Works
0.00
2-year mean citedness

Trust signals

1 of 3 signals present

Independent positive signals — not a single “predatory/legitimate” verdict, but a converging picture.

  • DOAJ
    No data
    doaj.org
  • OAK list
    No data
    OAK
  • Valid ISSN
    Present
    ISSN

This is an information label, not an official ruling. A missing signal is not a penalty — a regional journal may simply not be in DOAJ.

Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
051015200134520172018201920202021202220232024202520262017: Publications 8, Citations 02018: Publications 6, Citations 02019: Publications 2, Citations 12020: Publications 20, Citations 42021: Publications 10, Citations 42022: Publications 8, Citations 02023: Publications 17, Citations 02024: Publications 9, Citations 22025: Publications 8, Citations 12026: Publications 1, Citations 0

Citation history

0134520172018201920202021202220232024202520262017: Citations 02018: Citations 02019: Citations 12020: Citations 42021: Citations 42022: Citations 02023: Citations 02024: Citations 22025: Citations 12026: Citations 0

Publication history

0510152020172018201920202021202220232024202520262017: Publications 82018: Publications 62019: Publications 22020: Publications 202021: Publications 102022: Publications 82023: Publications 172024: Publications 92025: Publications 82026: Publications 1

h-index evolution

Cumulative h-index by year

01220172018201920202021202220232024202520262017: h-index 02018: h-index 02019: h-index 12020: h-index 12021: h-index 22022: h-index 22023: h-index 22024: h-index 22025: h-index 22026: h-index 2

Most-cited works

  1. Comparative Analysis Of The Inflammatory Biomarkers In Patients With Stable Coronary Artery Disease And Metabolic Syndrome20193 citations
  2. Combination lipid lowering therapy with rosuvastatin and ezetimibe in dyslipidemic patients with stable coronary artery disease and metabolic syndrome20182 citations
  3. Influence of diet with low glycemic index on triglycerides, glycated hemoglobin and LDL-C/HDL-C ratio in patients with coronary artery disease20202 citations
  4. Influence of combination therapy of rosuvastatin and telmisartan on vascular and metabolic profile in hypercholesterolemic patients with metabolic syndrome20171 citations
  5. Influence of high doses of atorvastatin on myocardial stanning in acute myocardial infarction20171 citations
  6. Efficiency and safety of rosuvastatin in patients with metabolic syndrome20171 citations
  7. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)20181 citations
  8. Prognostic value of metabolic syndrome for the development of type 2 diabetes mellitus and cardiovascular disease20201 citations
  9. Comparison of simvastatin and guar gum in the treatment hyperlipidemic patients with diabetes mellitus II type20000 citations
  10. Atherosclerotic lesions of the coronary arteries in patients with mitral heart disease with or without type 2 diabetes mellitus20140 citations
View in AkademIndex →